OraSure Technologies Inc (OSUR) - Product Pipeline Analysis, 2017 Update

OraSure Technologies Inc (OSUR) - Product Pipeline Analysis, 2017 Update

  • April 2017 •
  • 35 pages •
  • Report ID: 4890828 •
  • Format: PDF

Summary
OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to various hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company OraSure Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.